A Human-Safe Drug Reduces Multiple Signs of Alzheimer's in Mice
Science Alert,
Nifty!ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story…
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL‐286, a novel retinoic acid receptor‐β agonist for treatment of spinal cord injury, in male healthy participants
Overview of attention for article published in British Journal of Clinical Pharmacology, August 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (98th percentile)
Mentioned by
- news
- 15 news outlets
- blogs
- 2 blogs
- 11 X users
- wikipedia
- 1 Wikipedia page
- 5 Redditors
Readers on
- mendeley
- 13 Mendeley